Close Window

Digital Look Email A Friend

Sanofi to buy biopharmaceutical group Kymab for up to $1.45bn

Published by Michele Maatouk on 11th January 2021

(Sharecast News) - Sanofi has agreed to buy British clinical-stage biopharmaceutical company Kymab for up to $1.45bn.

URL: http://www.digitallook.com/dl/news/story/31562676/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.